Agios, Inc.

Agios ( is a biopharmaceutical company in the field of cellular metabolism to treat cancer and rare genetic diseases. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.